PCG-PHPCG-PHAMEX
Loading
PCG-PH Revenue Growth (YoY Quarterly)•+2.61%
Stock Alarm Pro
Growth Metrics
Latest: Q4 2025vs Q3 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
+2.61%
-2.6pp
+17.24%
-99.6pp
+19.31%
+24.1pp
+17.24%
+10.8pp
-0.59%
-47.4pp
-3.33%
-40.4pp
-3.33%
-36.7pp
+3.40%
+0.5pp
+2.56%
-3.9pp
+0.00%
+0.0pp
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -5.82% | +2.08% | -1.47% | +5.20% | +2.61% |
| Gross Profit Growth | -34.46% | -0.47% | +105.84% | +116.81% | +17.24% |
| EBITDA Growth | -1.15% | -0.35% | -0.24% | -4.83% | +19.31% |
| Operating Income Growth | -34.46% | -0.47% | -3.09% | +6.43% | +17.24% |
| Net Income Growth | -26.98% | -13.74% | +4.77% | +46.80% | -0.59% |
| EPS Growth | -30.23% | -17.65% | +0.00% | +37.04% | -3.33% |
| EPS Diluted Growth | -30.23% | -17.65% | +0.00% | +33.33% | -3.33% |
| Weighted Average Shares Growth | +3.73% | +2.86% | +2.85% | +2.85% | +3.40% |
| Weighted Average Shares Diluted Growth | +0.63% | +2.85% | +2.85% | +6.44% | +2.56% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +305.03% | +25.96% | +48.66% | -8.94% | +1.45% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | -115.21% | +0.00% |
| Receivables Growth | +21.88% | -1.41% | -3.99% | -15.85% | -7.81% |
| Inventory Growth | -5.75% | -3.90% | -4.50% | -6.03% | +0.00% |
| Asset Growth | +6.33% | +6.11% | +4.28% | +4.48% | +5.95% |
| Book Value per Share Growth | +16.07% | +15.94% | +15.49% | +15.86% | +4.38% |
| Debt Growth | +1.06% | +2.39% | -1.54% | -0.40% | +5.13% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
1 / 4